Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer

Chiara Nicolazzo; Francesca Belardinilli; Salvatore Caponnetto; Angela Gradilone; Enrico Cortesi; Giuseppe Giannini; Paola Gazzaniga

Journal ArticleOPEN ACCESS

Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer

Nicolazzo C
Belardinilli F
Caponnetto S
et al.

Frontiers in Oncology (2019) 9

DOI: 10.3389/fonc.2019.01414

8Citations

12Readers

Author supplied keywords

EGFR inhibitiors
RAS
colorectal cancer
ctDNA
liquid biopsy

Cite

CITATION STYLE

APA

Nicolazzo, C., Belardinilli, F., Caponnetto, S., Gradilone, A., Cortesi, E., Giannini, G., & Gazzaniga, P. (2019). Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer. Frontiers in Oncology, 9. https://doi.org/10.3389/fonc.2019.01414

Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer

Author supplied keywords

Cite

Register to see more suggestions